Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C010914 |
2,4-diaminotoluene |
2,4-diaminotoluene results in decreased expression of OGN mRNA | decreases expression | 20713471
|
C023514 |
2,6-dinitrotoluene |
2,6-dinitrotoluene affects the expression of OGN mRNA | affects expression | 21346803
|
C006780 |
bisphenol A |
bisphenol A results in decreased expression of OGN mRNA | decreases expression | 20739668
|
D002251 |
Carbon Tetrachloride |
Carbon Tetrachloride affects the expression of OGN mRNA | affects expression | 17484886
|
D002251 |
Carbon Tetrachloride |
Carbon Tetrachloride results in increased expression of OGN mRNA | increases expression | 16239168
|
C030123 |
coumarin |
coumarin results in decreased expression of OGN mRNA | decreases expression | 18480146
|
D003907 |
Dexamethasone |
[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in decreased expression of OGN mRNA | affects cotreatment|decreases expression | 16054899
|
D003907 |
Dexamethasone |
Tetrachlorodibenzodioxin inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in decreased expression of OGN mRNA] | affects cotreatment|decreases expression|decreases reaction | 16054899
|
D004997 |
Ethinyl Estradiol |
Ethinyl Estradiol results in increased expression of OGN mRNA | increases expression | 17942748
|
D004997 |
Ethinyl Estradiol |
[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of OGN mRNA | affects cotreatment|increases expression | 17942748
|
D004997 |
Ethinyl Estradiol |
Ethinyl Estradiol affects the expression of OGN mRNA | affects expression | 17351261
|
D015056 |
1-Methyl-3-isobutylxanthine |
[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in decreased expression of OGN mRNA | affects cotreatment|decreases expression | 16054899
|
D015056 |
1-Methyl-3-isobutylxanthine |
Tetrachlorodibenzodioxin inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in decreased expression of OGN mRNA] | affects cotreatment|decreases expression|decreases reaction | 16054899
|
D008748 |
Methylcholanthrene |
Methylcholanthrene results in decreased expression of OGN mRNA | decreases expression | 20713471
|
D010126 |
Ozone |
Ozone results in decreased expression of OGN mRNA | decreases expression | 12763052
|
D010656 |
Phenylephrine |
Phenylephrine results in decreased expression of OGN mRNA | decreases expression | 18158353
|
C089730 |
rosiglitazone |
[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in decreased expression of OGN mRNA | affects cotreatment|decreases expression | 16054899
|
C089730 |
rosiglitazone |
Tetrachlorodibenzodioxin inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in decreased expression of OGN mRNA] | affects cotreatment|decreases expression|decreases reaction | 16054899
|
D017632 |
Asbestos, Serpentine |
Asbestos, Serpentine results in decreased expression of OGN mRNA | decreases expression | 16251409
|
C017947 |
sodium arsenite |
sodium arsenite results in increased expression of OGN mRNA | increases expression | 17879257
|
C017947 |
sodium arsenite |
sodium arsenite results in increased expression of OGN mRNA | increases expression | 18812580
|
C017947 |
sodium arsenite |
sodium arsenite results in decreased expression of OGN mRNA | decreases expression | 19072884
|
D013749 |
Tetrachlorodibenzodioxin |
[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of OGN mRNA | affects cotreatment|increases expression | 17942748
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in decreased expression of OGN mRNA] | affects cotreatment|decreases expression|decreases reaction | 16054899
|
C025643 |
vinclozolin |
vinclozolin affects the expression of OGN mRNA | affects expression | 19015723
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
2.87 | 11752688 15322242 14514962 |
MESH:D000152 |
Acne Vulgaris |
|
Ethinyl Estradiol |
3.97 | 17505938 |
MESH:D000230 |
Adenocarcinoma |
|
Ethinyl Estradiol |
1.81 | 14692618 |
MESH:D000236 |
Adenoma |
|
Methylcholanthrene |
3.50 | 6695378 10545420 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
3.40 | 16835633 |
MESH:D000310 |
Adrenal Gland Neoplasms |
|
sodium arsenite |
4.73 | 15276417 |
MESH:D018246 |
Adrenocortical Adenoma |
|
sodium arsenite |
4.93 | 17306315 16712894 |
MESH:D000544 |
Alzheimer Disease |
|
Ozone |
4.49 | 15513908 |
MESH:D000544 |
Alzheimer Disease |
|
rosiglitazone |
4.49 | 19621015 |
MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
2.95 | 11748828 |
MESH:D001008 |
Anxiety Disorders |
|
vinclozolin |
3.64 | 19015723 |
MESH:D001145 |
Arrhythmias, Cardiac |
|
Phenylephrine |
4.11 | 17460149 |
MESH:D001161 |
Arteriosclerosis |
|
Ethinyl Estradiol |
3.48 | 11256880 |
MESH:D001169 |
Arthritis, Experimental |
|
Dexamethasone |
7.38 | 17659584 |
MESH:D001169 |
Arthritis, Experimental |
|
Ethinyl Estradiol |
7.38 | 15885639 |
MESH:D001172 |
Arthritis, Rheumatoid |
|
Ozone |
2.56 | 15570426 |
MESH:D001195 |
Asbestosis |
|
Asbestos, Serpentine |
5.68 | 10751356 |
MESH:D001249 |
Asthma |
|
Ozone |
2.64 | 16373670 17854713 |
MESH:D050197 |
Atherosclerosis |
|
Methylcholanthrene |
3.45 | 11922910 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
3.05 | 12125929 |
MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
3.82 | 15340226 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
2.76 | 15746008 |
MESH:D001862 |
Bone Resorption |
|
bisphenol A |
3.87 | 11985600 |
MESH:D001919 |
Bradycardia |
|
Phenylephrine |
4.56 | 15306635 |
MESH:D001943 |
Breast Neoplasms |
|
2,4-diaminotoluene |
2.02 | 11921183 |
MESH:D001943 |
Breast Neoplasms |
|
bisphenol A |
2.02 | 17123778 |
MESH:D001943 |
Breast Neoplasms |
|
Methylcholanthrene |
2.02 | 17474063 |
MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
2.02 | 20435547 |
MESH:D016535 |
Bronchial Hyperreactivity |
|
Ozone |
3.68 | 18315731 19059883 18417511 17626835 16777450 14754758 15516495 |
MESH:D002100 |
Cachexia |
|
Ozone |
4.76 | 16183385 |
MESH:D002252 |
Carbon Tetrachloride Poisoning |
|
Carbon Tetrachloride |
3.79 | 16124888 16192424 15673190 16227642 16011737 16050911 3786805 15721981 16097048 10355542 15700767 18705752 |
MESH:D002277 |
Carcinoma |
|
Methylcholanthrene |
8.34 | 10545420 |
MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
8.34 | 16835633 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
2,6-dinitrotoluene |
4.60 | 16705839 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Carbon Tetrachloride |
4.60 | 18788625 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
sodium arsenite |
4.60 | 15276417 17306315 16507464 |
MESH:D002278 |
Carcinoma in Situ |
|
bisphenol A |
5.01 | 17123778 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
sodium arsenite |
2.38 | 18572023 |
MESH:D006332 |
Cardiomegaly |
|
Phenylephrine |
6.89 | 15728586 17287366 17124262 16170337 11179087 11754973 |
MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
6.89 | 18850075 18670907 16120746 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
2,6-dinitrotoluene |
11.32 | 6135515 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Methylcholanthrene |
11.32 | 16192471 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
sodium arsenite |
11.32 | 19524636 20056578 |
MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
3.16 | 16835633 |
MESH:D002779 |
Cholestasis |
|
Ethinyl Estradiol |
2.88 | 15861022 16105132 11677210 17681005 17333356 17110522 16919318 |
MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
2.10 | 12621046 8697196 15668235 16354765 15340226 |
MESH:D003110 |
Colonic Neoplasms |
|
Dexamethasone |
2.49 | 15824018 |
MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
3.06 | 14669216 17141729 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Dexamethasone |
2.62 | 17728286 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
2.62 | 10048152 15322242 20055451 |
MESH:D003456 |
Cryptorchidism |
|
vinclozolin |
4.35 | 14966744 |
MESH:D003490 |
Cyanosis |
|
2,6-dinitrotoluene |
4.03 | 18551238 |
MESH:D017449 |
Dermatitis, Allergic Contact |
|
Dexamethasone |
3.42 | 12438553 |
MESH:D003920 |
Diabetes Mellitus |
|
rosiglitazone |
4.30 | 17446233 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
coumarin |
7.31 | 19647726 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
rosiglitazone |
7.31 | 12642470 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
7.31 | 17107852 |
MESH:D003967 |
Diarrhea |
|
Dexamethasone |
3.71 | 7237001 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
2,6-dinitrotoluene |
6.18 | 21346803 18551238 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Carbon Tetrachloride |
6.18 | 3786805 15968718 19336974 21278145 9327722 10915739 6623471 16177239 7179309 2869522 6884620 19085960 15998439 17522070 16227642 15027814 10092053 7440962 7120509 3732212 4309450 11566570 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
6.18 | 20420201 |
MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
2.76 | 11462148 |
MESH:D004485 |
Eczema |
|
Dexamethasone |
4.47 | 12438553 |
MESH:D004487 |
Edema |
|
Dexamethasone |
11.63 | 19703484 |
MESH:D004487 |
Edema |
|
rosiglitazone |
11.63 | 12083418 |
MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
11.63 | 11000095 12711302 |
MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
3.93 | 16714409 18230668 15322242 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Ethinyl Estradiol |
3.20 | 12538720 |
MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
3.02 | 10568697 9294722 |
MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
3.01 | 11564622 |
MESH:D005234 |
Fatty Liver |
|
Carbon Tetrachloride |
13.23 | 17595544 12795759 16239168 15959796 61145 12631006 16045604 19224547 |
MESH:D005234 |
Fatty Liver |
|
Ethinyl Estradiol |
13.23 | 15345470 |
MESH:D005234 |
Fatty Liver |
|
rosiglitazone |
13.23 | 19196556 |
MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
3.47 | 11858732 |
MESH:D005354 |
Fibrosarcoma |
|
Methylcholanthrene |
4.96 | 14633661 10962813 |
MESH:D005355 |
Fibrosis |
|
Carbon Tetrachloride |
8.64 | 18705752 |
MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
8.64 | 20067830 |
MESH:D030342 |
Genetic Diseases, Inborn |
|
vinclozolin |
4.95 | 16973722 |
MESH:D005832 |
Genital Diseases, Male |
|
vinclozolin |
5.33 | 16417039 |
MESH:D005833 |
Genital Neoplasms, Female |
|
sodium arsenite |
4.70 | 16452187 |
MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
4.62 | 10696789 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
2.33 | 10048152 11294989 |
MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
3.34 | 11000095 |
MESH:D006505 |
Hepatitis |
|
Carbon Tetrachloride |
3.60 | 19110552 19900420 |
MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
2.91 | 12621046 15340226 16120746 |
MESH:D006548 |
Hernia, Diaphragmatic |
|
Dexamethasone |
3.07 | 7520565 |
MESH:D006689 |
Hodgkin Disease |
|
sodium arsenite |
3.16 | 12676792 |
MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
4.08 | 15340226 18606429 8697196 16354765 16959395 |
MESH:D006930 |
Hyperalgesia |
|
rosiglitazone |
3.92 | 12083418 |
MESH:D006932 |
Hyperbilirubinemia |
|
Carbon Tetrachloride |
4.55 | 16899240 |
MESH:D006973 |
Hypertension |
|
Dexamethasone |
8.73 | 17042910 |
MESH:D006973 |
Hypertension |
|
Phenylephrine |
8.73 | 12717712 8949925 |
MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
8.73 | 18670907 18850075 |
MESH:D006975 |
Hypertension, Portal |
|
Carbon Tetrachloride |
4.10 | 15338365 |
MESH:D006984 |
Hypertrophy |
|
Phenylephrine |
4.56 | 18502941 12791704 |
MESH:D007021 |
Hypospadias |
|
Ethinyl Estradiol |
3.82 | 16569931 16945680 |
MESH:D007077 |
Ileal Diseases |
|
1-Methyl-3-isobutylxanthine |
5.47 | 18306037 |
MESH:D007247 |
Infertility, Female |
|
Ethinyl Estradiol |
3.47 | 12013081 |
MESH:D007248 |
Infertility, Male |
|
Ethinyl Estradiol |
11.22 | 17937319 |
MESH:D007248 |
Infertility, Male |
|
sodium arsenite |
11.22 | 12646999 15346721 |
MESH:D007248 |
Infertility, Male |
|
vinclozolin |
11.22 | 16467254 |
MESH:D007249 |
Inflammation |
|
Dexamethasone |
8.45 | 11099482 8960868 |
MESH:D007249 |
Inflammation |
|
rosiglitazone |
8.45 | 12083418 |
MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
8.45 | 12878042 12200463 |
MESH:D007333 |
Insulin Resistance |
|
bisphenol A |
7.75 | 16393666 |
MESH:D007333 |
Insulin Resistance |
|
rosiglitazone |
7.75 | 16306350 |
MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
3.34 | 16580747 |
MESH:D007579 |
Jejunal Diseases |
|
1-Methyl-3-isobutylxanthine |
5.47 | 18306037 |
MESH:D007674 |
Kidney Diseases |
|
sodium arsenite |
2.80 | 20008137 |
MESH:D007680 |
Kidney Neoplasms |
|
2,6-dinitrotoluene |
2.98 | 16705839 |
MESH:D007984 |
Leydig Cell Tumor |
|
vinclozolin |
4.75 | 16417039 |
MESH:D008103 |
Liver Cirrhosis |
|
Carbon Tetrachloride |
2.81 | 16943688 21278145 17157831 11408273 17174718 17334410 16239168 16221502 11903743 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Carbon Tetrachloride |
5.01 | 18429990 12898905 17869086 12632514 18481824 17766677 15057751 17805973 16116963 17922224 10355542 18412020 17900296 15338365 15052691 18376398 16033810 16638106 15893842 16192424 16097048 15818738 18006644 12586293 14716833 18210741 15370692 18187930 17721639 17631135 18472094 18277467 18395095 15931870 12649538 17714472 17698563 18395914 18705752 12632512 20821823 15730626 12741479 14716496 18156304 17708605 18420326 18472332 17976157 12546737 15959796 12666154 14620537 17823541 15996030 15123356 17944888 15673190 17481882 14748882 15925388 18251166 12958196 17761835 13678700 15362042 16011737 17557913 11481614 16015684 16027843 18339082 18054572 16248980 12445418 17640975 17565644 18166357 14724832 18263696 12389079 18317297 16136751 12445421 12667390 14512876 15650968 18205269 12609069 18418968 15876570 18279442 17525996 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Dexamethasone |
5.01 | 16718785 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
rosiglitazone |
5.01 | 17347453 15980055 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
5.01 | 12878042 |
MESH:D008107 |
Liver Diseases |
|
Carbon Tetrachloride |
2.08 | 15720792 16964402 15830285 16246199 17285989 |
MESH:D017093 |
Liver Failure |
|
Carbon Tetrachloride |
4.18 | 15123358 |
MESH:D017114 |
Liver Failure, Acute |
|
Carbon Tetrachloride |
3.69 | 16899240 14706259 |
MESH:D008113 |
Liver Neoplasms |
|
2,6-dinitrotoluene |
10.70 | 7678174 |
MESH:D008113 |
Liver Neoplasms |
|
Carbon Tetrachloride |
10.70 | 19294768 |
MESH:D008113 |
Liver Neoplasms |
|
sodium arsenite |
10.70 | 15276417 16712894 |
MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
10.70 | 16984957 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
2,6-dinitrotoluene |
14.15 | 6135515 2876786 2876784 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Carbon Tetrachloride |
14.15 | 15583823 12014681 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Methylcholanthrene |
14.15 | 598648 1399818 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
14.15 | 12151625 |
MESH:D008171 |
Lung Diseases |
|
Asbestos, Serpentine |
12.54 | 17200189 |
MESH:D008171 |
Lung Diseases |
|
Ozone |
12.54 | 8266340 19066396 |
MESH:D008171 |
Lung Diseases |
|
sodium arsenite |
12.54 | 19095001 |
MESH:D055370 |
Lung Injury |
|
Ozone |
3.86 | 20417186 |
MESH:D008175 |
Lung Neoplasms |
|
Asbestos, Serpentine |
8.58 | 11198217 |
MESH:D008175 |
Lung Neoplasms |
|
Dexamethasone |
8.58 | 11195469 15824018 |
MESH:D008175 |
Lung Neoplasms |
|
Methylcholanthrene |
8.58 | 15390079 9230183 20512841 20970405 17909032 16271038 21163286 1399818 11893704 7750092 6695378 16337739 10545420 |
MESH:D008175 |
Lung Neoplasms |
|
Ozone |
8.58 | 7614698 8597069 |
MESH:D008175 |
Lung Neoplasms |
|
sodium arsenite |
8.58 | 16712894 15276417 17306315 17077188 19931552 |
MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
8.58 | 19555203 11884234 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
2,4-diaminotoluene |
6.63 | 11921183 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
rosiglitazone |
6.63 | 16827153 |
MESH:D008545 |
Melanoma |
|
sodium arsenite |
2.03 | 16487513 19082730 |
MESH:D024821 |
Metabolic Syndrome X |
|
rosiglitazone |
4.38 | 17261469 |
MESH:D008679 |
Metaplasia |
|
Ozone |
5.14 | 10496685 |
MESH:D009101 |
Multiple Myeloma |
|
Dexamethasone |
3.51 | 15744524 16118317 15867202 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
Dexamethasone |
3.54 | 9809623 |
MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
3.02 | 12213967 |
MESH:D009336 |
Necrosis |
|
2,6-dinitrotoluene |
3.88 | 7678174 18551238 |
MESH:D009369 |
Neoplasms |
|
sodium arsenite |
2.50 | 11559025 |
MESH:D009374 |
Neoplasms, Experimental |
|
Asbestos, Serpentine |
9.58 | 11704859 |
MESH:D009374 |
Neoplasms, Experimental |
|
sodium arsenite |
9.58 | 20056578 |
MESH:D009421 |
Nervous System Malformations |
|
bisphenol A |
9.61 | 11399458 16427766 |
MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
9.61 | 14600291 |
MESH:D009436 |
Neural Tube Defects |
|
sodium arsenite |
3.14 | 12854658 |
MESH:D009784 |
Occupational Diseases |
|
2,6-dinitrotoluene |
3.43 | 16049721 |
MESH:D010049 |
Ovarian Diseases |
|
bisphenol A |
5.01 | 11985600 |
MESH:D010051 |
Ovarian Neoplasms |
|
sodium arsenite |
2.43 | 17306315 15276417 |
MESH:D016584 |
Panic Disorder |
|
Ethinyl Estradiol |
3.69 | 11578682 |
MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
4.28 | 12520081 |
MESH:D010538 |
Peritonitis |
|
Ozone |
4.14 | 16369182 |
MESH:D010995 |
Pleural Diseases |
|
Asbestos, Serpentine |
5.71 | 10923243 |
MESH:D011014 |
Pneumonia |
|
Ozone |
4.41 | 18007984 18381685 18929643 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
3.57 | 18163543 |
MESH:D054198 |
Precursor Cell Lymphoblastic Leukemia-Lymphoma |
|
Dexamethasone |
3.54 | 21297632 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
bisphenol A |
16.39 | 10548101 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
16.39 | 11222880 11896295 11118676 11399792 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
vinclozolin |
16.39 | 19015723 18220299 18042343 |
MESH:D011469 |
Prostatic Diseases |
|
vinclozolin |
4.95 | 18220299 |
MESH:D019048 |
Prostatic Intraepithelial Neoplasia |
|
bisphenol A |
4.21 | 20887781 |
MESH:D011471 |
Prostatic Neoplasms |
|
bisphenol A |
3.35 | 16740699 |
MESH:D011471 |
Prostatic Neoplasms |
|
sodium arsenite |
3.35 | 16039940 |
MESH:D011472 |
Prostatitis |
|
vinclozolin |
4.95 | 18629315 |
MESH:D011537 |
Pruritus |
|
Ethinyl Estradiol |
3.33 | 16919318 15861022 |
MESH:D011629 |
Puberty, Precocious |
|
bisphenol A |
4.81 | 10548101 |
MESH:D011658 |
Pulmonary Fibrosis |
|
Asbestos, Serpentine |
3.83 | 18569384 15511213 |
MESH:D012128 |
Respiratory Distress Syndrome, Adult |
|
Dexamethasone |
4.02 | 11700416 18379247 |
MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
3.85 | 18990726 |
MESH:D012640 |
Seizures |
|
2,6-dinitrotoluene |
2.54 | 18551238 |
MESH:D012852 |
Sinusitis |
|
Phenylephrine |
4.72 | 7327846 |
MESH:D012878 |
Skin Neoplasms |
|
sodium arsenite |
5.60 | 19524636 18572023 |
MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
5.60 | 16192470 |
MESH:D013088 |
Spermatocele |
|
Ethinyl Estradiol |
3.97 | 16709447 |
MESH:D016135 |
Spinal Dysraphism |
|
sodium arsenite |
3.80 | 12854658 |
MESH:D013272 |
Stomach Diseases |
|
Dexamethasone |
4.34 | 15472012 |
MESH:D013276 |
Stomach Ulcer |
|
Dexamethasone |
3.49 | 15138204 |
MESH:D019966 |
Substance-Related Disorders |
|
bisphenol A |
4.00 | 16684133 16045194 |
MESH:D019851 |
Thrombophilia |
|
Ethinyl Estradiol |
3.63 | 11994571 |
MESH:D013927 |
Thrombosis |
|
Ethinyl Estradiol |
3.15 | 15669648 |
MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
3.93 | 12697716 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
2,6-dinitrotoluene |
5.10 | 16049721 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
sodium arsenite |
5.10 | 11723127 16452187 16712894 17306315 |
MESH:D014571 |
Urologic Neoplasms |
|
2,6-dinitrotoluene |
4.34 | 10091137 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
sodium arsenite |
3.77 | 11813266 |
MESH:D014591 |
Uterine Diseases |
|
bisphenol A |
5.04 | 14652134 |
MESH:D014594 |
Uterine Neoplasms |
|
Ethinyl Estradiol |
3.31 | 14692618 |
MESH:D014605 |
Uveitis |
|
Dexamethasone |
4.85 | 1336536 |
MESH:D014652 |
Vascular Diseases |
|
sodium arsenite |
4.44 | 17056641 |
MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
4.62 | 12125929 |
MESH:D014689 |
Venous Insufficiency |
|
coumarin |
5.81 | 12708602 |
MESH:D020246 |
Venous Thrombosis |
|
Ethinyl Estradiol |
3.54 | 15869587 14671159 |
MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
4.28 | 15886252 |